Individualized Prognosis in MS – clinical cases
24 April 2021, Expert meeting. : How is an MS patient’s disease likely to progress over time? Will the patient be stable on a first-line therapy, or will the disease progress quickly if not treated aggressively? Professors Bart Van Wijmeersch and Celia Oreja-Guevara share with you their wealth of experience concerning patient prognosis.